Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Clin Colon Rectal Surg ; 37(1): 30-36, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38188064

ABSTRACT

Inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer. When IBD patients develop a rectal cancer, this should be treated with the same oncological principles and guidelines as the general population. Rectal cancer treatment includes surgery, chemotherapy, and radiation therapy (RT). Many IBD patients will require a total proctocolectomy with an ileal-pouch anal anastomosis (IPAA) and others, restoration of intestinal continuity may not be feasible or advisable. The literature is scarce regarding outcomes of IPAA after RT. In the present review, we will summarize the evidence regarding RT toxicity in IBD patients and review surgical strategies and outcomes of IPAA after RT.

2.
J Laparoendosc Adv Surg Tech A ; 29(3): 360-365, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30207856

ABSTRACT

BACKGROUND: The aim of this study is to report our experience with laparoscopic common bile duct exploration (LCBDE) and validate the experts' opinion about anatomical predictors of failed transcystic LCBDE (TLCBDE) approach. METHODS: Patients undergoing LCBDE at Kaiser Permanente Southern California hospitals (2005-2015) were included. Predictors of failed TLCBDE were identified using bivariate analysis. RESULTS: Of 115 LCBDE, 89.6% were TLCBDE and 10.4% through choledochotomy. Success rate, morbidity, and length of hospital stay were 83.5%, 6.1%, and 3.8 days respectively. Only stone size:cystic duct ratio >1 (35% versus 63%, P = .044) was associated with failure of TLCBDE. In accordance with experts' opinion, there was a suggestive association of stone size ≥6 mm, cystic duct ≤4 mm, multiple stones, and proximal stone location with failure; however, these did not reach statistical significance. CONCLUSION: LCBDE is an effective and safe mean of clearing common bile duct stones at community hospitals of an integrated health system. Previously cited contraindications for TLCBDE are not absolute, but rather predictors of failure.


Subject(s)
Biliary Tract Surgical Procedures/adverse effects , Cholecystectomy, Laparoscopic/adverse effects , Choledocholithiasis/surgery , Common Bile Duct/surgery , Laparoscopy/adverse effects , Adult , Aged , Biliary Tract Surgical Procedures/methods , California , Cholecystectomy, Laparoscopic/methods , Databases, Factual , Delivery of Health Care, Integrated , Female , Humans , Laparoscopy/methods , Length of Stay/statistics & numerical data , Male , Middle Aged , Postoperative Complications/etiology , Retrospective Studies , Treatment Outcome
3.
Am Surg ; 84(10): 1679-1683, 2018 Oct 01.
Article in English | MEDLINE | ID: mdl-30747694

ABSTRACT

Same-day endoscopic retrograde cholangiopancreatography (ERCP) and cholecystectomy (LC) could potentially reduce hospital length of stay (HLOS). Patients undergoing same-day procedures (N = 164) between 2012 and 2014 were compared with different-day procedures performed in the second half of 2014 (N = 276), in the Kaiser Permanente Southern California database. Both groups had comparable baseline characteristics. ERCP success rate (97.5% vs 93.5%), overall postoperative morbidity (3.66% vs 3.99%), and retained stones (2.5% vs 5.8%) were not different between groups (P > 0.05); however, HLOS was shorter in the same-day group (2.99 ± 2.34 vs 3.84 ± 2.52 days, P < 0.001). Morbidity, procedure success, and HLOS were not different in the same-day group, whether ERCP was performed before or after LC (P > 0.05). In the same-day group, those undergoing single anesthesia had higher BMI (40.1 ± 10.8 vs 30.3 ± 6.6) and were more likely to have gastric bypass (30% vs 0%) than those undergoing separate anesthesia sessions (P < 0.01). Longer HLOS (4.8 ± 3.5 vs 2.9 ± 2.2 days) and higher estimated blood loss (65 ± 90 mL vs 20 ± 29 mL) were also associated with the single-anesthetic session (P < 0.01). ERCP performed on the same day of LC reduces HLOS without increasing morbidity. This approach does not affect postoperative morbidity and ERCP success rate, whether ERCP was performed before or after LC.


Subject(s)
Ambulatory Surgical Procedures/statistics & numerical data , Cholangiopancreatography, Endoscopic Retrograde/statistics & numerical data , Cholecystectomy, Laparoscopic/statistics & numerical data , Choledocholithiasis/surgery , Blood Loss, Surgical/statistics & numerical data , California , Cholangiopancreatography, Endoscopic Retrograde/adverse effects , Cholecystectomy, Laparoscopic/adverse effects , Female , Humans , Length of Stay/statistics & numerical data , Male , Middle Aged , Patient Readmission/statistics & numerical data , Patient Safety , Postoperative Complications/etiology , Retrospective Studies , Treatment Outcome
4.
J Endourol ; 29(8): 919-24, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25793265

ABSTRACT

PURPOSE: To compare perioperative outcomes of open (OSP) and minimally invasive (MISP) simple prostatectomy for benign prostatic hyperplasia (BPH) in a large national cohort using validated patient safety measures. PATIENTS AND METHODS: We studied patients undergoing simple prostatectomy for BPH in the Nationwide Inpatient Sample (NIS) from 1998 to 2010 and used weighted sampling to estimate national trends. Patient safety indicators (PSI) and multivariable regression were used to generate adjusted odds ratios (ORadj) comparing OSP with MISP. RESULTS: We identified 34,418 and 193 patients undergoing OSP and MISP, respectively. Although the overall frequency of simple prostatectomy cases decreased from 3157 cases in 1998 to 2227 cases in 2010, the annual frequency increased each year from 2008 to 2010. We focused on 2008 to 2010 for the comparative outcome analyses. Among all OSP cases during this period (n=6027), the transfusion prevalence was 21%. MISP patients were more likely to have higher Charlson comorbidity scores (P=0.11) and less likely to undergo transfusion (P=0.13), but these differences did not attain significance. There were no significant differences in median length of stay (LOS) (P=0.19), hospital charges (P=0.15), or unadjusted in-hospital mortality (P=0.73). PSI frequency was low, and did not differ significantly between groups (ORadj 1.59, 95% confidence interval 0.26 to 9.53, P=0.61). CONCLUSIONS: In this, the first national analysis of simple prostatectomy, use of both OSP and MISP rose substantially from 2008 to 2010. Although transfusion prevalence was lower and LOS shorter for MISP, these differences did not attain significance. Further comparative analyses are needed.


Subject(s)
Prostatectomy/methods , Prostatic Hyperplasia/surgery , Aged , Blood Transfusion/statistics & numerical data , Comorbidity , Female , Hospital Mortality , Humans , Length of Stay/statistics & numerical data , Male , Odds Ratio , Patient Safety , Prostatectomy/mortality , Treatment Outcome
5.
Int Braz J Urol ; 39(2): 209-13, 2013.
Article in English | MEDLINE | ID: mdl-23683685

ABSTRACT

INTRODUCTION: To date, there is a paucity of literature offering practicing urologists a reference for the amount of radiation exposure received while surgically managing urolithiasis. This study examines the cumulative radiation exposure of an urologist over 9 months. MATERIALS AND METHODS: We present a case series of fluoroscopic exposures of an experienced stone surgeon operating at an academic comprehensive stone center between April and December 2011. Radiation exposure measurements were determined by a thermoluminescent dosimeter worn on the outside of the surgeon's thyroid shield. Estimations of radiation exposure (mrem) per month were charted with fluoroscopy times, using scatter plots to estimate Spearman's rank correlation coefficients. RESULTS: The total 9-month radiation exposure was 87 mrems for deep dose equivalent (DDE), 293 mrem for lens dose equivalent (LDE), and 282 mrem for shallow dose equivalent (SDE). Total fluoroscopy time was 252.44 minutes for 64 ureteroscopies (URSs), 29 percutaneous nephrolithtomies (PNLs), 20 cystoscopies with ureteral stent placements, 9 shock wave lithotripsies (SWLs), 9 retrograde pyelograms (RPGs), 2 endoureterotomies, and 1 ureteral balloon dilation. Spearman's rank correlation coefficients examining the association between fluoroscopy time and radiation exposure were not significant for DDE (p = 0.6, Spearman's rho = 0.2), LDE (p = 0.6, Spearman's rho = 0.2), or SDE (p = 0.6, Spearman's rho = 0.2). CONCLUSIONS: Over a 9-month period, total radiation exposures were well below annual accepted limits (DDE 5000 mrem, LDE 15,000 mrem and SDE 50,000 mrem). Although fluoroscopy time did not correlate with radiation exposure, future prospective studies can account for co-variates such as patient obesity and urologist distance from radiation source.


Subject(s)
Occupational Exposure/analysis , Radiation Monitoring/methods , Urology , Fluoroscopy/adverse effects , Humans , Occupational Exposure/standards , Radiation Dosage , Radiation Monitoring/instrumentation , Reference Standards , Reference Values , Retrospective Studies , Risk Assessment , Statistics, Nonparametric , Time Factors , Urolithiasis/diagnostic imaging , Urolithiasis/surgery
6.
Int. braz. j. urol ; 39(2): 209-13, Mar-Apr/2013. tab, graf
Article in English | LILACS | ID: lil-676254

ABSTRACT

Introduction To date, there is a paucity of literature offering practicing urologists a reference for the amount of radiation exposure received while surgically managing urolithiasis. This study examines the cumulative radiation exposure of an urologist over 9 months. Materials and Methods We present a case series of fluoroscopic exposures of an experienced stone surgeon operating at an academic comprehensive stone center between April and December 2011. Radiation exposure measurements were determined by a thermoluminescent dosimeter worn on the outside of the surgeon's thyroid shield. Estimations of radiation exposure (mrem) per month were charted with fluoroscopy times, using scatter plots to estimate Spearman's rank correlation coefficients. Results The total 9-month radiation exposure was 87 mrems for deep dose equivalent (DDE), 293 mrem for lens dose equivalent (LDE), and 282 mrem for shallow dose equivalent (SDE). Total fluoroscopy time was 252.44 minutes for 64 ureteroscopies (URSs), 29 percutaneous nephrolithtomies (PNLs), 20 cystoscopies with ureteral stent placements, 9 shock wave lithotripsies (SWLs), 9 retrograde pyelograms (RPGs), 2 endoureterotomies, and 1 ureteral balloon dilation. Spearman's rank correlation coefficients examining the association between fluoroscopy time and radiation exposure were not significant for DDE (p = 0.6, Spearman's rho = 0.2), LDE (p = 0.6, Spearman's rho = 0.2), or SDE (p = 0.6, Spearman's rho = 0.2). Conclusions Over a 9-month period, total radiation exposures were well below annual accepted limits (DDE 5000 mrem, LDE 15,000 mrem and SDE 50,000 mrem). Although fluoroscopy time did not correlate with radiation exposure, future prospective studies can account for co-variates such as patient obesity and urologist distance from radiation source. .


Subject(s)
Humans , Occupational Exposure/analysis , Radiation Monitoring/methods , Urology , Fluoroscopy/adverse effects , Occupational Exposure/standards , Radiation Dosage , Reference Standards , Reference Values , Retrospective Studies , Risk Assessment , Radiation Monitoring/instrumentation , Statistics, Nonparametric , Time Factors , Urolithiasis , Urolithiasis/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...